Ignite Creation Date:
2025-12-24 @ 2:34 PM
Ignite Modification Date:
2025-12-31 @ 10:16 AM
Study NCT ID:
NCT00265759
Status:
COMPLETED
Last Update Posted:
2025-04-23
First Post:
2005-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-01
Start Date Type:
ACTUAL
Primary Completion Date:
2012-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-27
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-14
First Submit QC Date:
None
Study First Post Date:
2005-12-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-14
Results First Submit QC Date:
None
Results First Post Date:
2017-03-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-04
Last Update Post Date:
2025-04-23
Last Update Post Date Type:
ACTUAL